Point-of-care testing of coagulation in patients treated with edoxaban

作者
Florian Härtig,Ingvild Birschmann,Andreas Peter,Sebastian Hörber,Matthias Ebner,Matthias Sonnleitner,Charlotte Spencer,Paula Bombach,Maria‐Ioanna Stefanou,Joachim Kühn,Annerose Mengel,Ulf Ziemann,Sven Poli
出处
期刊:Journal of Thrombosis and Thrombolysis [Springer Science+Business Media]
卷期号:50 (3): 632-639 被引量:17
标识
DOI:10.1007/s11239-020-02143-2
摘要

Edoxaban, alongside other direct oral anticoagulants (DOAC), is increasingly used for prevention of thromboembolism, including stroke. Despite DOAC therapy, however, annual stroke rate in patients with atrial fibrillation remains 1-2%. Rapid exclusion of relevant anticoagulation is necessary to guide thrombolysis or reversal therapy but, so far, no data exists on the effect of edoxaban on available point-of-care test systems (POCT). To complete our previous investigation on global coagulation-POCT for the detection of DOAC, we evaluated whether CoaguChek®-INR (CC-INR) is capable of safely ruling out edoxaban concentrations above the current treatment thresholds of 30/50 ng/mL in a blood sample. We studied patients receiving a first dose of edoxaban; excluding subjects receiving other anticoagulants. Six blood samples were collected from each patient: before drug intake, 0.5, 1, 2 and 8 h after intake, and at trough (24 h). CC-INR and mass spectrometry for edoxaban concentrations were performed for each time-point. One hundred and twenty blood samples from 20 patients contained 0-302 ng/mL of edoxaban. CC-INR ranged from 0.9 to 2.3. Pearson's correlation coefficient showed strong correlation between CC-INR and edoxaban concentrations (r = 0.73, p < 0.001). Edoxaban concentrations > 30 and > 50 ng/mL were ruled out by CC-INR ≤ 1.0 and ≤ 1.1, respectively, with high specificity (> 95%), and a sensitivity of 44% (95%-confidence interval: 30-59%) and 86% (74-93%), respectively. Our study represents the first evaluation of coagulation-POCT in edoxaban-treated patients. CC-POCT is suitable to safely exclude clinically relevant edoxaban concentrations prior to thrombolysis, or guide reversal therapy in stroke patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
今后的应助被xiaoxue采纳,获得10
1秒前
casino的应助被敏静采纳,获得10
1秒前
单薄谷秋发布了新的文献求助10
1秒前
英俊的铭的应助被咻咻采纳,获得10
2秒前
韶枫发布了新的文献求助10
2秒前
mTOR完成签到,获得积分10
3秒前
3秒前
3秒前
4秒前
科研通AI6.3的应助被MMLi采纳,获得10
5秒前
lethe发布了新的文献求助10
5秒前
5秒前
叶林海发布了新的文献求助10
5秒前
故渊丶完成签到 ,获得积分10
5秒前
6秒前
6秒前
JamesPei的应助被tong采纳,获得10
6秒前
7秒前
7秒前
科研通AI6.4的应助被自然白安采纳,获得20
7秒前
XX发布了新的文献求助10
8秒前
邓三问完成签到,获得积分20
8秒前
zjh完成签到,获得积分20
8秒前
8秒前
8秒前
9秒前
黄健丰完成签到,获得积分10
10秒前
11秒前
曲奇发布了新的文献求助10
11秒前
11秒前
邓三问发布了新的文献求助10
11秒前
12秒前
12秒前
SciGPT的应助被kdjc采纳,获得10
12秒前
xiaomaihua发布了新的文献求助20
12秒前
史卓曼发布了新的文献求助30
12秒前
13秒前
隐形曼青的应助被单薄谷秋采纳,获得10
13秒前
轻松的翎发布了新的文献求助10
14秒前
crown1010完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193514
求助须知:如何正确求助?哪些是违规求助? 9579686
关于积分的说明 21866883
捐赠科研通 7793152
什么是DOI,文献DOI怎么找? 3437297
关于科研通互助平台的介绍 2560725
邀请新用户注册赠送积分活动 2484176